🇫🇷 Spineway
ALSPW.PAFundamentals
Gross Margin
26.3%
Op. Margin
-17.2%
Net Margin
-18.0%
ROIC
-7.6%
Rev Growth
4.0%
Valuation
Price
0.12 EUR
Day
+0.00%
52-Week Range
0.11 - 0.26
Market Cap
4M EUR
Fwd P/E
-
EV/EBITDA
-
Div Yield
-
Annual income statement #
Spineway annual revenue, operating income and net income in EUR, 2016 to 2025. Revenue was 12.4m in 2025.
| Year | Revenue (EUR) | Operating income | Net income | Net margin |
|---|---|---|---|---|
| 2025 | 12.4m | -2.1m | -2.2m | -18.0% |
| 2024 | 11.9m | -5.8m | -3.9m | -32.3% |
| 2023 | 10.5m | -4.5m | -6.5m | -61.9% |
| 2022 | 7.4m | -6.4m | -3.1m | -42.2% |
| 2021 | 4.3m | -1.2m | -1.6m | -36.9% |
| 2020 | 3.4m | -1.5m | -14.0m | |
| 2019 | 5.6m | -2.3m | -2.9m | -51.5% |
| 2018 | 6.9m | -3.9m | -4.1m | -59.7% |
| 2017 | 9.6m | -845,000 | -965,000 | -10.1% |
| 2016 | 5.1m | -2.3m | -2.7m | -52.8% |
Financial Data #
Segment Breakdown #
Peers #
SDOS.ST NEOLA.ST QLIFE.ST ALBLU.PA REDS.ST ZENI.ST CLS-B.ST PERP-B.ST SMSMED.CO ARCOMA.ST ·
Compare in Screener
Dividends
Bubble
Events #
| Date | Type | Details | Price | Amount |
|---|